Newborn screening is essential to improve diagnosis and outcomes

Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Newborn screening is essential to improve diagnosis and outcomes

Alpharmaxim work closely with industry to provide education around newborn screening and can help to drive awareness of newborn screening panels. It is important to increase the number of newborn screening panels and harmonise their number and size across Europe. Newborn screening:

Allows for early diagnosis and, therefore, management of rare genetic diseases
Could have a significant impact on the burden on healthcare systems and patients/families
Could lead to a reduction in later misdiagnosis and suffering

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

Talk to us about how we can transform your communications

World Parkinson's Day 2023

For World Parkinson’s Day 2023, Alpharmaxim created an animation to highlight some of the Parkinson's symptoms to look out for – in yourself and others.

We need to talk about vaccine hesitancy

Why do some individuals opt out of vaccination or prevent their children from being vaccinated? Are all forms of hesitancy or rejection illogical?

Let's talk about vaccine hesitancy

Vaccination can be a complex, personal matter, and there are a number of reasons why individuals may be hesitant.